Daniel Dines Sells 45,000 Shares of UiPath, Inc. (NYSE:PATH) Stock

UiPath, Inc. (NYSE:PATH - Get Free Report) CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction dated Monday, July 14th. The stock was sold at an average price of $12.44, for a total value of $559,800.00. Following the completion of the sale, the chief executive officer owned 5,148,376 shares of the company's stock, valued at $64,045,797.44. The trade was a 0.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Daniel Dines also recently made the following trade(s):

• On Friday, July 11th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.71, for a total transaction of $571,950.00.
• On Wednesday, July 9th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $13.17, for a total transaction of $592,650.00.
• On Monday, July 7th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $13.11, for a total value of $589,950.00.
• On Wednesday, July 2nd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.54, for a total value of $564,300.00.
• On Monday, June 30th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.78, for a total transaction of $575,100.00.
• On Friday, June 27th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.78, for a total transaction of $575,100.00.
• On Wednesday, June 25th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.55, for a total transaction of $564,750.00.
• On Monday, June 23rd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.10, for a total transaction of $544,500.00.

UiPath Stock Up 0.9%

NYSE PATH traded up $0.12 on Monday, reaching $12.47. The company had a trading volume of 9,710,152 shares, compared to its average volume of 11,326,955. The stock has a market capitalization of $6.67 billion, a PE ratio of -103.87, a price-to-earnings-growth ratio of 16.18 and a beta of 1.04. UiPath, Inc. has a 12 month low of $9.38 and a 12 month high of $15.93. The firm's 50 day moving average price is $12.72 and its 200 day moving average price is $12.46.

UiPath (NYSE:PATH - Get Free Report) last posted its earnings results on Thursday, May 29th. The company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. The company had revenue of $356.62 million for the quarter, compared to the consensus estimate of $332.17 million. UiPath had a negative return on equity of 3.05% and a negative net margin of 4.65%. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.13 earnings per share. On average, research analysts expect that UiPath, Inc. will post -0.17 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of PATH. AdvisorNet Financial Inc raised its stake in UiPath by 320.4% during the second quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company's stock valued at $32,000 after purchasing an additional 1,887 shares in the last quarter. Versant Capital Management Inc raised its position in shares of UiPath by 198.6% during the 1st quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock valued at $31,000 after buying an additional 1,970 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of UiPath by 141.4% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,974 shares of the company's stock valued at $38,000 after acquiring an additional 1,742 shares during the last quarter. GAMMA Investing LLC grew its position in UiPath by 48.0% in the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company's stock worth $38,000 after acquiring an additional 969 shares in the last quarter. Finally, CX Institutional bought a new stake in UiPath during the first quarter worth approximately $36,000. 62.50% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on PATH. Evercore ISI lifted their target price on UiPath from $11.00 to $15.00 and gave the company an "in-line" rating in a research report on Friday, May 30th. Canaccord Genuity Group set a $16.00 price objective on UiPath and gave the company a "buy" rating in a research note on Monday, June 2nd. Royal Bank Of Canada raised their target price on shares of UiPath from $13.00 to $15.00 and gave the stock a "sector perform" rating in a research note on Friday, May 30th. Mizuho lowered their price target on shares of UiPath from $12.00 to $11.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Finally, Wells Fargo & Company reissued an "equal weight" rating on shares of UiPath in a research note on Friday, May 30th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, UiPath presently has a consensus rating of "Hold" and an average target price of $13.83.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.